phase readout
saveTrial primary completion: The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome
December 1, 2026updated 7d ago
community read0 votes
Sponsor: Children's Hospital of Chongqing Medical University. Status: Active, not recruiting. Conditions: Primary Nephrotic Syndrome. NCT07612592.
view source ↗Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that